Table 1.
All (117) | Men (52) | Women (65) | |
---|---|---|---|
Age at diagnosis, years (mean, SD) | 24.3 (4.9) | 23.9 (4.8) | 24.6 (5.0) |
Age at time of diagnosis, years (mean, SD) | 6.7 (4.3) | 7.2 (4.3) | 6.3 (4.3) |
Time since cancer, years (mean, SD) | 17.6 (6.0) | 16.7 (5.8) | 18.3 (6.2) |
Ethnicity, n (%) | |||
African American | 13 (11%) | 4 (8%) | 9 (14%) |
White, non-Hispanic | 84 (72%) | 41 (79%) | 43 (83%) |
Hispanic | 15 (13%) | 4 (8%) | 11 (17%) |
Cranial radiotherapy, n (%) | 40 (34%) | 15 (29%) | 25 (38%) |
Anthracycline chemotherapy, n (%) | 84 (72%) | 42 (81%) | 42 (65%) |
Dexamethasone, n (%) | 13 (11%) | 4 (8%) | 9 (14%) |